An independent model, in which human A3B (as a turbo-GFP fusion) is integrated at the Col1a1 locus and expressed inducibly using a R26-integrated tetracycline transactivator,20 also yields modest A3B expression levels and no significant tumor phenotypes (Figure S2). This evidence concerns the gene APOBEC3B and neoplasm.